Cargando…
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
Patients with head and neck squamous cell carcinoma (HNSCC) continue to have a rather poor prognosis. Treatment-related comorbidities have negative impacts on their quality of life. TRIM21 is a cytosolic E3 ubiquitin ligase that was initially described as an autoantigen in autoimmune diseases and la...
Autores principales: | von Bernuth, Amelie, Ribbat-Idel, Julika, Klapper, Luise, Jagomast, Tobias, Rades, Dirk, Leichtle, Anke, Pries, Ralph, Bruchhage, Karl-Ludwig, Perner, Sven, Offermann, Anne, Sailer, Verena, Idel, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048917/ https://www.ncbi.nlm.nih.gov/pubmed/36982215 http://dx.doi.org/10.3390/ijms24065140 |
Ejemplares similares
-
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022) -
NR2F6 as a Prognostic Biomarker in HNSCC
por: Klapper, Luise, et al.
Publicado: (2020) -
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020) -
CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer
por: Jagomast, Tobias, et al.
Publicado: (2022) -
Increased Abundances of CD16(+) Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4(+) T Cell Disturbances in Oropharyngeal Cancer
por: Idel, Christian, et al.
Publicado: (2022)